← Insider buys
OCUL

Ocular Therapeutix, Inc. · Healthcare

Chief Medical Officer Nadia Waheed sold $123K of Ocular Therapeutix, Inc.

Sold$122,628
$8.27Price
14,828Shares
−5%Stake

What OCUL did after the filing

Filed Jun 5Copier in Jun 8
The stock from Mon, Jun 8 open, $8.31
+3.3%
S&P 500, same days
+0.5%

Measured over 30 trading days, to the Jul 22 close.

Traded Wed, Jun 3. Filed Fri, Jun 5, 4:01 PM ET, after the close. Returns use the Jun 8 open and the Jul 22 close. Not investment advice.